HRPT2 inactivating mutations in the germline occur in the hyperparathyroidism-jaw tumor (HPT-JT) syndrome, characterized by hyperparathyroidism (parathyroid adenoma or carcinoma) (90%), fibrous-ossifying jaw tumors (30%), and bilateral renal cysts (10%) [1,2]. Here, CDC73 is linked to hyperparathyroidism.